About
Olympus Endoscopy AI represents Olympus America's integration of artificial intelligence into its flagship endoscopy and surgical imaging platforms. At the core is the EVIS X1™ Endoscopy System, which incorporates computer-aided detection (CADe) and computer-aided diagnosis (CADx) capabilities to assist clinicians in identifying polyps, lesions, and other abnormalities in real time during procedures. Designed for use by trained healthcare professionals, the AI-assisted tools are embedded within Olympus's broader ecosystem of endoscopy hardware and imaging solutions — spanning gastroenterology, pulmonology, ENT, urology, gynecology, and general surgery. The Olympus Knowledge Exchange (KE) System ties imaging and workflow management together, enabling seamless data capture and review. Olympus's AI tools are built to complement existing clinical workflows, helping to reduce adenoma miss rates and improve procedural consistency. The platform also integrates with OlympusConnect, a customer portal that centralizes service, training, and clinical resources. Targeted at hospitals, ambulatory surgical centers (ASCs), and specialty clinics, Olympus Endoscopy AI is a regulated medical device ecosystem backed by Olympus's deep investment in R&D and manufacturing. It is sold exclusively through authorized medical channels under applicable FDA regulations. The solution is particularly relevant for gastroenterologists performing colonoscopies and endoscopists in high-volume clinical environments seeking quality and detection improvements.
Key Features
- AI-Assisted Detection (CADe/CADx): Real-time computer-aided detection and diagnosis embedded in the EVIS X1™ system helps clinicians identify polyps and lesions during live endoscopic procedures.
- EVIS X1™ Endoscopy Platform: Flagship endoscopy system combining 4K imaging, AI tools, and advanced optical technology for superior mucosal visualization across GI and surgical applications.
- Olympus Knowledge Exchange (KE) System: Integrated imaging and workflow management platform that captures, organizes, and shares procedural data across clinical teams and facilities.
- Multi-Specialty Coverage: AI-enhanced endoscopy solutions span gastroenterology, pulmonology, ENT, urology, gynecology, neurosurgery, and general surgery.
- OlympusConnect Customer Portal: Centralized digital portal providing service management, clinical resources, account information, and product support for healthcare institutions.
Use Cases
- Gastroenterologists performing colonoscopies use AI-assisted polyp detection to reduce adenoma miss rates and improve screening outcomes.
- Pulmonologists leverage AI-integrated bronchoscopy systems for enhanced visualization and staging of lung lesions.
- Ambulatory surgical centers adopt the EVIS X1™ platform to standardize high-quality endoscopic imaging and AI-assisted workflows across their facilities.
- Hospital systems use the Olympus Knowledge Exchange System to centralize procedural imaging data and streamline clinical documentation.
- Infection prevention teams rely on Olympus's integrated product ecosystem to ensure compliant reprocessing and safe patient care across endoscopy suites.
Pros
- Clinically Validated AI Integration: AI detection tools are embedded in FDA-regulated medical devices, ensuring clinical reliability and regulatory compliance for real-world procedural use.
- Comprehensive Multi-Specialty Ecosystem: A single vendor offering AI-powered imaging across numerous specialties reduces integration complexity for hospitals and ASCs.
- Workflow and Imaging Management Built-In: The Knowledge Exchange System streamlines procedural data capture and sharing, supporting efficient clinical documentation and review.
Cons
- Enterprise-Only Pricing: Available exclusively through institutional procurement channels with no transparent public pricing, making evaluation difficult without direct sales engagement.
- Hardware Dependency: AI capabilities are tied to specific Olympus hardware platforms, limiting flexibility for institutions with existing third-party endoscopy equipment.
- US Market Focus: The site and support infrastructure are primarily designed for US-based healthcare professionals, with limited self-serve resources for international users.
Frequently Asked Questions
Olympus Endoscopy AI refers to the artificial intelligence capabilities integrated into Olympus's endoscopy platforms, particularly the EVIS X1™ system, which uses computer-aided detection (CADe) and diagnosis (CADx) to help clinicians identify polyps and lesions in real time.
These systems are intended for licensed healthcare professionals — including gastroenterologists, pulmonologists, and surgeons — operating in hospitals, outpatient clinics, and ambulatory surgical centers (ASCs).
Yes. Olympus medical devices sold in the US are subject to FDA regulation. Federal law restricts these devices to sale by or on the order of a physician, and they are cleared for specified clinical indications per their labeling.
The AI-assisted detection runs in real time during endoscopic examinations, analyzing the live video feed to highlight potential polyps or lesions on-screen, helping clinicians avoid missing clinically significant findings.
Institutions can contact Olympus America directly through their website or via OlympusConnect. Corporate account programs, GPO/IDN contracting, and leasing/financing options are available for hospitals and ASCs.